Teva Fights Eli Lilly's Bid To Toss Migraine Drug IP Case
By Adam Lidgett · October 19, 2021, 5:14 PM EDT
Teva Pharmaceuticals says that Eli Lilly shouldn't be able to dodge a suit alleging an Eli Lilly migraine drug infringes a pair of Teva patents, arguing that the complaint is adequately...
To view the full article, register now.